Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Author's Avatar
Jul 01, 2021

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules.